Skip to main content

Advertisement

Table 1 Characteristics of Behçet’s disease (BD) patients and healthy controls

From: Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease

Demographics Active BD Inactive BD Healthy control
Age (mean ± SD) 41.86 ± 7.54 43.6 ± 8.04 38.93 ± 6.94
Sex (male:female) 6:9 7:8 7:8
Clinical characteristics of BD patients Case number (%)   
 Major symptoms    
  Oral ulcer 15 (100)   
  Genital ulcer 10 (67)   
  Skin lesion 10 (67)   
  Ocular lesion 4 (27)   
 Minor symptoms    
  Arthritis 2 (13)   
  GI involvement 1 (7)   
  Epididymitis 0   
  Cardiovascular 1 (7)   
  CNS involvement 1 (7)   
Medication    
 Immunosuppressive agenta 6 (40) 0 (0)  
 Anti-inflammatory drugsb 9 (60) 7 (46)  
  1. aMethylprednisolone 8–24 mg/d
  2. bColchicine 1.2 mg/d ± minocycline 100 mg/d ± pentoxiphylline 800 mg/d ± sulfasalazine 1000 mg/d